The Valley Desk

ArticleClinical lymphoma, myeloma & leukemiaPublished

Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Article
Venue
Clinical lymphoma, myeloma & leukemia
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Treatment Outcome; Retrospective Studies; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized
PubMed ID
40348718
Added to directory
Source checked

Report a correction or request removal